In diabetes, excessive FTO downregulates TNIP1, a central regulator of inflammation, thereby activating NF-κB and subsequently increasing inflammatory cytokines (IL-1β and IL-18) in an m6A-dependent manner, ultimately leading to vascular endothelial dysfunction (Figure 8). Here, FTO is linked to diabetes mellitus.